Skip to main content
Contact Us
Subscribe
E-Edition
70°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xencor Inc
(NQ:
XNCR
)
24.11
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Xencor Inc
< Previous
1
2
3
Next >
Xencor Appoints Bart Cornelissen as Chief Financial Officer
April 09, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at Upcoming Investor Conferences
February 28, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
February 20, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Xencor, Inc.
Via
Business Wire
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
January 02, 2024
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million
November 07, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
November 03, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023
October 31, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Announces Planned Retirement of Chief Financial Officer John Kuch
October 26, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present Multiple Posters at the SITC Annual Meeting
September 27, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors
September 19, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023
July 27, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 Congress
May 30, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Reports First Quarter 2023 Financial Results
May 08, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023
May 01, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
April 26, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023
April 17, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present Preclinical Data from Novel XmAb® CD28 Bispecific Antibody Programs at the American Association for Cancer Research Annual Meeting 2023
March 14, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023
February 16, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From
Xencor, Inc.
Via
Business Wire
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
January 13, 2023
Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.
Via
MarketBeat
Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates
January 09, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Data from Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin Lymphoma at the American Society of Hematology Annual Meeting
December 12, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at Upcoming Investor Conferences
November 10, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Early Clinical Data from Combination Study of Vudalimab and New Data from Multiple Preclinical-stage XmAb® Programs at the SITC Annual Meeting
November 10, 2022
From
Xencor, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.